Pharma market grows 9% in Feb on price increase, new products
India's pharmaceutical market witnessed a robust 9% month-on-month growth in February, driven by strong performance in cardiology and anti-infective therapies. However, the respiratory segment saw negative growth in both value and units. The growth was primarily attributed to price increases and new product launches. Antibiotic Augmentin retained its position as the top-selling drug, with other key players including Rosuvas, Thyronorm, Liv 52, and Pan. Anti-diabetic drug Rybelsus continued its triple-digit growth trend. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2024 Category: Pharmaceuticals Source Type: news

Indian pharma market grows over 9 per cent in December
Among the top therapies, cardiac, anti-infectives and neuro/central nervous system have shown a relatively stronger volume growth last month, according to data from research firm PharmaTrac. Antibiotic drug Augmentin and anti-diabetes Glycomet GP continued to be the top-selling medicine brands. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 9, 2024 Category: Pharmaceuticals Source Type: news

Five-Day Antibiotic Course Noninferior for Pediatric Febrile UTI
TUESDAY, Dec. 26, 2023 -- For young children with febrile urinary tract infection (fUTI), a five-day amoxicillin-clavulanate course is noninferior to a 10-day course for recurrence of UTI within 30 days after completion of therapy, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 26, 2023 Category: Pharmaceuticals Source Type: news

GSK's Augmentin is India's no.1 drug brand
Research firm PharmaTrac data shows Augmentin sales at Rs 801 crore from November 2022-23. For the month of November, Augmentin sales stood at Rs 75 crore. It has shown a moving annual total (MAT) growth growth of 12.3%. As per the data, Glycomet GP sales stood at Rs 774 crore from same period and the sales for November stood at Rs 64 crore. It has shown a MAT growth of 7.5%. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 8, 2023 Category: Pharmaceuticals Source Type: news

Amoxicillin Alone for Acute Sinusitis Holds Up Against Broad-Spectrum Cousin
(MedPage Today) -- Treatment failure with amoxicillin-clavulanate for pediatric acute sinusitis was similar compared with amoxicillin alone, but the broad-spectrum antibiotic may be associated with more adverse events, an examination of a large... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 22, 2023 Category: American Health Source Type: news

Treatment Failure Similar for Amoxicillin +/ − Clavulanate for Pediatric Acute Sinusitis
THURSDAY, Sept. 21, 2023 -- There is no difference in the risk for treatment failure for outpatient children with acute sinusitis treated with amoxicillin-clavulanate compared with amoxicillin, according to a study published in the Sept. 19 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 21, 2023 Category: Pharmaceuticals Source Type: news

Study Finds Two Antibiotics for Children with Sinusitis Equally Effective, But One Had Fewer Side Effects
Brigham researchers found that patients prescribed amoxicillin-clavulanate had higher rates of gastrointestinal symptoms and yeast infections than those prescribed amoxicillin. (Source: BWH News)
Source: BWH News - September 19, 2023 Category: Hospital Management Source Type: news

Study Finds Two Antibiotics for Children with Sinusitis Equally Effective, But One Had Fewer Side Effects
Brigham researchers found that patients prescribed amoxicillin-clavulanate had higher rates of gastrointestinal symptoms and yeast infections than those prescribed amoxicillin (Source: BWH News)
Source: BWH News - September 19, 2023 Category: Hospital Management Source Type: news

Why should I be evaluated for a penicillin allergy?
Taking action to be evaluated for a penicillin allergy can impact your health, safety and wallet. According to the Centers for Disease Control and Prevention, 10% of the U.S. population reports a penicillin allergy, but less than 1% is allergic after testing. Common penicillins include ampicillin, amoxicillin and Augmentin. Penicillin allergy is an abnormal reaction of your immune system to the antibiotic drug prescribed for treating various bacterial infections. These medications are used often to treat ear… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 14, 2022 Category: Databases & Libraries Source Type: news

America runs out of FOUR child antibiotics and flu drugs as kids bear brunt of 'tripledemic' 
Four crucial drugs for fighting respiratory illnesses are in short supply in America amid the 'tripledemic'. It has been hard to find Augmentin, amoxicillin, Tamiflu and albuterol. (Source: the Mail online | Health)
Source: the Mail online | Health - November 22, 2022 Category: Consumer Health News Source Type: news

Augmentin (amoxicillin/clavulanic acid, Augmentin XR, Augmentin ES-600, Amoclan)
Title: Augmentin (amoxicillin/clavulanic acid, Augmentin XR, Augmentin ES-600, Amoclan)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 12/2/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 2, 2021 Category: Drugs & Pharmacology Source Type: news

Amoxicillin-Clavulanate Effective for Outpatients With Diverticulitis
TUESDAY, Feb. 23, 2021 -- For immunocompetent patients with diverticulitis in the outpatient setting, amoxicillin-clavulanate is as effective as metronidazole with fluoroquinolone, according to a study published online Feb. 23 in the Annals of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 23, 2021 Category: Pharmaceuticals Source Type: news

Diverticulitis: A New Standard of Care? Diverticulitis: A New Standard of Care?
Clinicians may opt for a fluoroquinolone-sparing approach by using amoxicillin-clavulanate, with no drop in efficacy, new data indicate.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - February 22, 2021 Category: Emergency Medicine Tags: Gastroenterology News Source Type: news

How Are Dental Abscesses Treated?
Discussion Dental caries are one of the most common infections. It is usually caused by Streptococcus viridans. Dental caries are also quite preventable with brushing the teeth at least twice a day with a fluoridated dentifrice, use of dental floss, and preventative dental appointments with application of fluoride varnish and sealants as appropriate. Additionally, fluoridation of the community water supply has significantly decreased dental caries and is a very effective public health measure. Fluoride binds within the dental matrix to strength it. Dental abscesses are usually caused by poor oral hygiene but others are at...
Source: PediatricEducation.org - August 24, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

$1.77M award gives Temple researchers chance to investigate therapy for cocaine addiction
(Temple University Health System) Researchers at the Lewis Katz School of Medicine at Temple University have received a new $1.77M grant from the National Institute on Drug Abuse that will allow them to explore whether a drug called clavulanic acid can help patients recover from cocaine use disorder. Clavulanic acid is part of an existing therapy known as Augmentin. Augmentin combines clavulanic acid with the penicillin-related antibiotic amoxicillin and is used for the treatment of bacterial infections. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 15, 2020 Category: International Medicine & Public Health Source Type: news